The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Implementation and evaluation of multi-cancer early detection testing at the Dana-Farber Cancer Institute: A retrospective analysis of clinical outcomes and diagnostic pathways.
 
Elizabeth O'Donnell
Honoraria - Exact Sciences; Sanofi
Consulting or Advisory Role - BMS; Janssen; Legend Biotech ; Natera; Takeda
Research Funding - Amgen (Inst); Janssen (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exact Sciences; Sanofi
 
Tia Kauffman
No Relationships to Disclose
 
Jenna Beckwith
No Relationships to Disclose
 
Rachel Yore
No Relationships to Disclose
 
Ciola Bennett
No Relationships to Disclose
 
Mary O'Malley
No Relationships to Disclose
 
Marjorie Marto
No Relationships to Disclose
 
Jennifer Carroll
No Relationships to Disclose
 
Giovanni Parmigiani
No Relationships to Disclose
 
Timothy Rebbeck
No Relationships to Disclose
 
Irene Ghobrial
Employment - Disc Medicine (I)
Leadership - Disc Medicine (I)
Stock and Other Ownership Interests - Disc Medicine (I); Predicta Biosciences
Honoraria - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Curio Science; Janssen; Menarini Silicon Biosystems; Regeneron; Sanofi; Takeda; Vor Biopharma
Consulting or Advisory Role - 10X Genomics; Abbvie; Abbvie; Adaptive Biotechnologies; Amgen; Aptitude Health; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Menarini Silicon Biosystems; Novartis; Pfizer; Regeneron; Sanofi; Standard Biotools; Takeda; The Binding Site
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Takeda
 
Sapna Syngal
Consulting or Advisory Role - Natera
Research Funding - Biological Dynamics
Patents, Royalties, Other Intellectual Property - Dana-Farber Cancer Institute has a registered service mark for the PREMM5 model and holds copyrights for the PREMM questionnaires (Inst); Myriad Genetics (through Dana-Farber Cancer Institute) paid an inventor share of the IP (license issue fee)
Expert Testimony - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Pancreatic Cancer Action Network
 
Catherine Marinac
Honoraria - Exact Sciences
Consulting or Advisory Role - Exact Sciences; Natera